Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G van der Zee

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smearG B Wisman, H Hollema, S de Jong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancerM D Esajas, J M Duk, H W de Bruijn, et al.
Cancer|December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisalC van Haaften-Day, Y Shen, F Xu, et al.
Journal of the National Cancer Institute|August 16, 1995
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinomaM A Izquierdo, A G van der Zee, J B Vermorken, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervixH W de Bruijn, J M Duk, A G van der Zee, et al.
Clinical and Experimental Rheumatology|June 16, 2001
An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detectionE B van Leeuwen, G B Wisman, J W Tervaert, et al.
International Journal of Cancer|February 18, 2011
Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancerNinke Leffers, Renee Vermeij, Baukje-Nynke Hoogeboom, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
Gynecologic Oncology|January 11, 2011
Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trialClaudia B Bijen, Karin M Vermeulen, Marian J Mourits, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smearG B Wisman, H Hollema, S de Jong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2001
Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancerM D Esajas, J M Duk, H W de Bruijn, et al.
Cancer|December 26, 2001
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisalC van Haaften-Day, Y Shen, F Xu, et al.
Journal of the National Cancer Institute|August 16, 1995
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinomaM A Izquierdo, A G van der Zee, J B Vermorken, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 18, 1998
The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervixH W de Bruijn, J M Duk, A G van der Zee, et al.
Clinical and Experimental Rheumatology|June 16, 2001
An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detectionE B van Leeuwen, G B Wisman, J W Tervaert, et al.
International Journal of Cancer|February 18, 2011
Long-term clinical and immunological effects of p53-SLP® vaccine in patients with ovarian cancerNinke Leffers, Renee Vermeij, Baukje-Nynke Hoogeboom, et al.
British Journal of Cancer|May 18, 2001
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantationC P Schröder, G B Wisman, S de Jong, et al.
Gynecologic Oncology|January 11, 2011
Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trialClaudia B Bijen, Karin M Vermeulen, Marian J Mourits, et al.
Genes, Chromosomes & Cancer|April 18, 2009
Do microsatellite instability profiles really differ between colorectal and endometrial tumors?Ana M Ferreira, Helga Westers, Ying Wu, et al.
Pageof 8